由买买提看人间百态

boards

本页内容为未名空间相应帖子的节选和存档,一周内的贴子最多显示50字,超过一周显示500字 访问原贴
Biology版 - Pfizer Retracts 5 Articles(通讯疑似老中)
相关主题
请问有没有GSK3b和proteasome 的促进剂PNAS和Plos pathogen那个好?
求问:why癌细胞的heat shock protein高,普通细胞低?PLoS ONE's 2009 impact factor is 4.351
也说说Nature这期的retraction饶教授重金挖入的 “青千” 论文被撤稿了 (转载)
AKT308与AKT473磷酸化调控的关系大家怎么看?韩副主席是不是发个retraction也能过关?
韩春雨论文正式撤稿这个哈佛stem cell 图造假和当年肖恩的类似了
这个稿子撤的有点滑稽a question for 'Kinase' experts
Pfizer will cut 1.1k jobs in southern Connecticutp21 protein (Cdc42/Rac) 和p21 (CDKN1A)是同一个蛋白么?
postdoc at Pfizer or MIT (转载)amino acid/ receptor与mTOR
相关话题的讨论汇总
话题: cancer话题: pfizer话题: et话题: al话题: breast
进入Biology版参与讨论
1 (共1页)
D***s
发帖数: 5613
1
Min-Jean Yin,
Pfizer (PFE) Retracts 5 Articles Authored by Top Cancer Researcher Who Has
Since Left the Company
After 13 years as a senior principal scientist for Pfizer (PFE), oncology
researcher Min-Jean Yin has departed the company and five cancer research
papers in which she had a hand in crafting have since been retracted due to
questionable data, Leonid Schneider, a Germany-based science writer posted
on his For Better Science site on Oct. 11.
五篇撤稿:
1. Nassirpour et. al, miR-221 Promotes Tumorigenesis in Human Triple
Negative Breast Cancer Cells, 8(4) PLOS ONE, (2013);
2. Baxi et. al, Targeting 3-Phosphoinoside-Dependent Kinase-1 to Inhibit
Insulin-Like Growth Factor-I Induced AKT and p70 S6 Kinase Activation in
Breast Cancer Cells, 7(10) PLOS ONE (2012);
3. Mehta et. al, A novel class of specific Hsp90 small molecule inhibitors
demonstrate in vitro and in vivo anti-tumor activity in human melanoma cells
, 300 Cancer Letters 30 (2011);
4. Mehta et. al, Effective Targeting of Triple-Negative Breast Cancer Cells
by PF-4942847, a Novel Oral Inhibitor of Hsp 90, 17(6) Clinical Cancer
Research 5432, 2011; and
5. Nassirpour et. al, Nek6 Mediates Human Cancer Cell Transformation And Is
A Potential Cancer Therapeutic Target, 8(5) Molecular Cancer Research 717 (
2010).
http://www.biospace.com/News/pfizer-retracts-5-articles-authored-by-top-cancer/435418?type=email&source=DD_101216
G***G
发帖数: 16778
2
strange.
why did company request this withdrawing?

to

【在 D***s 的大作中提到】
: Min-Jean Yin,
: Pfizer (PFE) Retracts 5 Articles Authored by Top Cancer Researcher Who Has
: Since Left the Company
: After 13 years as a senior principal scientist for Pfizer (PFE), oncology
: researcher Min-Jean Yin has departed the company and five cancer research
: papers in which she had a hand in crafting have since been retracted due to
: questionable data, Leonid Schneider, a Germany-based science writer posted
: on his For Better Science site on Oct. 11.
: 五篇撤稿:
: 1. Nassirpour et. al, miR-221 Promotes Tumorigenesis in Human Triple

1 (共1页)
进入Biology版参与讨论
相关主题
amino acid/ receptor与mTOR韩春雨论文正式撤稿
怎样设计小实验来确定一个基因编码的蛋白质是protein kinase这个稿子撤的有点滑稽
The Top 10 Retractions of 2015(zz)Pfizer will cut 1.1k jobs in southern Connecticut
国自然基金委对方舟子的实名举报有反应么?postdoc at Pfizer or MIT (转载)
请问有没有GSK3b和proteasome 的促进剂PNAS和Plos pathogen那个好?
求问:why癌细胞的heat shock protein高,普通细胞低?PLoS ONE's 2009 impact factor is 4.351
也说说Nature这期的retraction饶教授重金挖入的 “青千” 论文被撤稿了 (转载)
AKT308与AKT473磷酸化调控的关系大家怎么看?韩副主席是不是发个retraction也能过关?
相关话题的讨论汇总
话题: cancer话题: pfizer话题: et话题: al话题: breast